UA35555C2 - benzimidazole Derivatives and pharmaceutical composition HAVING ANTAGONISTIC activity relative to angiotensin - Google Patents

benzimidazole Derivatives and pharmaceutical composition HAVING ANTAGONISTIC activity relative to angiotensin

Info

Publication number
UA35555C2
UA35555C2 UA93002794A UA93002794A UA35555C2 UA 35555 C2 UA35555 C2 UA 35555C2 UA 93002794 A UA93002794 A UA 93002794A UA 93002794 A UA93002794 A UA 93002794A UA 35555 C2 UA35555 C2 UA 35555C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
benzimidazole
angiotensin
pyridine
antagonistic activity
Prior art date
Application number
UA93002794A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Норберт Хауель
Бертхольд НАРР
Уве РІС
Меель Жак ван
Вольфганг ВІНЕН
Міхаель ЕНТЦЕРОТ
Original Assignee
Др. Карл Томе Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Др. Карл Томе Гмбх filed Critical Др. Карл Томе Гмбх
Publication of UA35555C2 publication Critical patent/UA35555C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to novel pyrimidine–containing derivatives having biological activity and pharmaceutical composition based thereon. Derivatives of benzimidazole of the general formula (1) EMBED ISISServer (1) where: r1 = C1-Сз-alkyl or C1, R2 = in position 6: benzimidazole-2-yl, tetrahydrobenzimidazole-1-yl, 1-methyl benzimidazole-2-yl, phthalimidobenzimidazole-1-yl, 1-oxoimidazole-2-yl, 1-oxoisoindole-2-yl, 2-oxopiperidine-1-yl, butansultam-1-yl, N-benzosulfonylmethylamino, imidazo[1,2-a]pyridine-2-yl, 5, 6, 7, 8-tetrahydroimidazo[1,2-a]pyridine-2-yl, imidazo[2,1-b]thiazol-6-yl, pyridine-2-yl, 1-isopropylimidazole-4-yl, isopropylcarbonylamino, 2,3-dimethylmaleinimido, morpholinecarbonylamino, cyclohexylaminocarbonylamino, amidino or, in the position 7, group of the formula EMBED ISISServer where: n=2-5, Rз = Et, n-Pr, n-Bu, R4 = CO2H or 1H-tetrazol-5-yl, in the form of a mixture of isomers, separate isomers, hydrates and salts.
UA93002794A 1991-02-06 1993-04-16 benzimidazole Derivatives and pharmaceutical composition HAVING ANTAGONISTIC activity relative to angiotensin UA35555C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4103492A DE4103492A1 (en) 1991-02-06 1991-02-06 New 1-(1,4-bi:phenyl-methyl) benzimidazole(s) as angiotensin II antagonists
DE4137812A DE4137812A1 (en) 1991-02-06 1991-11-16 New 1-(1,4-bi:phenyl-methyl) benzimidazole(s) as angiotensin II antagonists

Publications (1)

Publication Number Publication Date
UA35555C2 true UA35555C2 (en) 2001-04-16

Family

ID=6424446

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93002794A UA35555C2 (en) 1991-02-06 1993-04-16 benzimidazole Derivatives and pharmaceutical composition HAVING ANTAGONISTIC activity relative to angiotensin

Country Status (9)

Country Link
KR (1) KR100218820B1 (en)
BR (1) BR1100667A (en)
DE (4) DE4103492A1 (en)
EE (1) EE03085B1 (en)
NO (1) NO1999024I1 (en)
TW (1) TW208015B (en)
UA (1) UA35555C2 (en)
YU (1) YU48849B (en)
ZA (1) ZA92816B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
DE10314702A1 (en) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of telmisartan
CN113307775B (en) * 2021-04-16 2022-04-22 河北戴桥医药科技有限公司 Preparation method of telmisartan

Also Published As

Publication number Publication date
YU48849B (en) 2002-06-19
YU9892A (en) 1999-03-04
KR920016431A (en) 1992-09-24
DE4137812A1 (en) 1993-05-19
EE03085B1 (en) 1998-04-15
NO1999024I1 (en) 1999-11-30
DE4103492A1 (en) 1992-10-08
BR1100667A (en) 2000-06-13
DE122011000013I1 (en) 2011-12-01
TW208015B (en) 1993-06-21
KR100218820B1 (en) 1999-09-01
ZA92816B (en) 1993-07-05
DE4117121A1 (en) 1992-12-17

Similar Documents

Publication Publication Date Title
HK1012246A1 (en) Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists
CA2296665A1 (en) Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents
BG102478A (en) N-([1,2,4]triazolazinyl)benzenesulphonamide and pyridinesulphanamide compunds and their application as herbicides
AU4243793A (en) 6-amino substituted imidazo(4,5-b)pyridines as angiotensin ii antagonists
IL100677A0 (en) Optically active 5h-pyrrolo(3,4-b)pyrazine derivative,its preparation and pharmaceutical compositions containing it
HU9401317D0 (en) Antiviral 2-ethyl - 1h imidazo (4,5-c) quinolin-4-amines
EP0503838A3 (en) Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
ATE89547T1 (en) DOPAMINE PRECURSORS.
DE69921483D1 (en) Imidazo [1,2-a] pyridine compounds which inhibit gastric acid secretion, pharmaceutical compositions containing them and processes for their preparation
CA2384037A1 (en) Pyrazolo[4,3-d]pyrimidines
EP0537937A3 (en) Substituted pyrazino 2,3-d pyrimidinones as angiotensin ii antagonists
IL82117A (en) Substituted 4h-imidazo(1,5-a)benzodiazepin-6-one derivatives,their preparation and pharmaceutical compositions containing them
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
IL82356A (en) 2-substituted pyrazolo(1,5-a)pyrimidine derivatives and herbicidal compositions containing them
EP0499416A3 (en) Pyridine compounds as angiotensin ii antagonists, processes for their preparation and pharmaceutical compositions containing them
CA2168131A1 (en) Tetrahydro-1h-benzazepinones containing acid surrogates
UA35555C2 (en) benzimidazole Derivatives and pharmaceutical composition HAVING ANTAGONISTIC activity relative to angiotensin
ZA952529B (en) Imidazo[1,2-a]-indeno[1,2-e]pyrazin-4-one derivatives and preparation thereof
MY131322A (en) Pharmaceutical compounds
GR1002883B (en) Novel 2,3 benzodiazepine derivatives
IT1276167B1 (en) IMIDAZO (1,2-ALPHA) QUINOSSALIN-4-AMINE ACTIVE AS ADENOSINE ANTAGONISTS, PROCEDURE FOR THEIR PREPARATION AND COMPOSITIONS
NZ229346A (en) Oxadiazolyl-substituted imidazo(1,5-a)quinoxaline derivatives and pharmaceutical compositions
ES8604589A1 (en) Imidazo[1,5-a]pyrimidine derivatives and process for their preparation.
MY103766A (en) Pyrrolo[1,2-a]imidazole and imidazo[1,2-a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
FI940607A0 (en) Imidazo (5,1-C) (1,4) benzoxazin-1-one derivatives as 5HT3 antagonists